Back

Cyclic guanosine monophosphate enhancing therapeutic strategy for heart failure with preserved ejection fraction (cGETS study): effects on cardiac dysfunction and remodeling.

28 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 6 - Chronic heart failure – pathophysiology and mechanisms Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Elisa Dal Canto

University Medical Center Utrecht, Utrecht (Netherlands (The))

14 More presentations in this session

Presentation thumbnail
Doctor K. Okuno (Philadelphia, US)
Abstract
Presentation thumbnail
Doctor S. Minatoguchi (Gifu, JP)
Abstract
Presentation thumbnail
Ms C. Binder (Vienna, AT)
Abstract
Presentation thumbnail
Ms C. Binder (Vienna, AT)
Abstract
Presentation thumbnail
Doctor T. Omori (Tsu , Mie, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 6 - Chronic heart failure – pathophysiology and mechanisms

The Event

Event poster

ESC Congress 2018

28 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Session
Transforming heart failure care: unlocking new pathways
19 May 2025
thumbnail
Congress Presentation
Assessment of cardiac reverse remodeling in patients with LV systolic dysfunction receiving vericiguat in addition to optimal GDMT
13 December 2024
thumbnail
Congress Presentation
The ghrelin receptor agonist AC01 improves cardiac function in non-human primates and in mice with heart failure by increasing cardiomyocyte contractility
30 August 2024
thumbnail
Congress Presentation
A soluble guanylate cyclase stimulator improves survival in a rat model of heart failure with reduced ejection fraction and chronic kidney disease induced by aorto-caval fistula and 5/6 nephrectomy
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources